Ophthalmologists with the most and largest payments had highest rates of injection with aflibercept and ranibizumab. Medscape Medical News
Tag: Ophthalmology
Face-On With JINS SCREEN NIGHT Blue Light Blocking Glasses
JINS, a popular Japanese eyewear company, recently released their JINS SCREEN NIGHT lenses in the U.S. These glasses were developed to alleviate the negative effects that bright blue light from electronic screens can have on our circadian rhythms, quality of sleep, and how we feel in the morning. Modern gadgets tend to be pretty bright, […]
The post Face-On With JINS SCREEN NIGHT Blue Light Blocking Glasses appeared first on Medgadget.
Corticosteroids as a Therapy for Bacterial Keratitis
Corticosteroids may be another viable treatment option for bacterial keratitis. Which patients will need and most benefit from this therapy? The British Journal of Ophthalmology
Faster Glaucoma Progress Tied to Higher Fall Rate
Glaucoma patients with rapid visual field (VF) loss are at greater risk of falls than those with slower progression, new research shows Reuters Health Information
Canon’s Telemedicine Technology Improves Screening for Diabetic Retinopathy (Interviews)
While this editor has often covered digital health within startups and early-stage projects, telemedicine innovation is not just the purview of small companies and healthcare incubators. Since 1976, Canon, Inc., the same multinational corporation that has been making cameras and other imaging devices since 1937, has also been involved in healthcare. Today, we’re looking at Canon’s efforts to […]
The post Canon’s Telemedicine Technology Improves Screening for Diabetic Retinopathy (Interviews) appeared first on Medgadget.
Poll: Ophthalmologists Eager to Use Corneal Crosslinking
A Medscape poll finds US ophthalmologists eager to access the newly FDA-approved keratoconus treatment that the majority of the world has enjoyed for some time. Medscape Medical News
Two Expensive Diabetic Macular Edema Drugs Not Cost-effective
Anti-VEGF medicines aflibercept and ranibizumab would have to drop in price by 69% and 80%, respectively, to be worth the societal cost compared with bevacizumab, a new study has found. Medscape Medical News
UK Regulatory Authority Grants Clinical Trial Approval for Pixium Vision’s Bionic Vision System
Medgadget previously reported on a preclinical trial by Pixium Vision, a company based in Paris, France, showing that its visual implants restore sight in rats with retinal degeneration. Pixium Vision is making headlines again with a recent announcement that the UK regulatory authority, Medicines & Healthcare products Regulatory Agency (MHRA), has granted clinical trial approval […]
The post UK Regulatory Authority Grants Clinical Trial Approval for Pixium Vision’s Bionic Vision System appeared first on Medgadget.
Adverse Events Linked With Anesthesia in Cataract Surgery
Learn more about the potentially serious complications of local anesthesia for cataract surgery. The British Journal of Ophthalmology
Early Evaluation for Head Tilt in Asymmetrical Epiblepharon
Children with asymmetrical epiblepharon should be evaluated for head tilt as early as possible so that facial asymmetry might be prevented, according to researchers from Korea. Reuters Health Information
Glaucoma Drugs May Skew Eye Pressure Readings
Chronic use of prostaglandin analogues (PGAs) may cause reversible corneal changes contributing to underestimation of intraocular pressure (IOP) in glaucoma patients, according to Canadian researchers. Reuters Health Information
Does Anti-VEGF Therapy Affect Cataract Surgery Complications?
Is the cataract surgery complication rate higher in patients receiving anti-VEGF injections? Dr Sophie Bakri comments on this study from Ophthalmology. Medscape Ophthalmology
Added Benefits Seen With Early Initiation of Anti-VEGF Agents for Diabetic Retinopathy
Dr Charles C. Wykoff reviews recent data showing that more timely treatment has a significant upside. Medscape Ophthalmology
5 Key Ophthalmology Takeaways: ASCRS 2016
Attendees in New Orleans were greeted with innovative theories and technologies that may change our treatment of glaucoma, cataracts, corneal ectasia, and other ophthalmic conditions. Medscape Ophthalmology
The Case of the Blue/Brown-Eyed Girl
A 2-year-old girl presents with unusual pigmentation in one eye and hearing issues. Can you make the correct diagnosis? Medscape Ophthalmology
South Carolina Bans Remote Exams for Eyeglass Prescriptions
Optometrists’ and ophthalmologists’ associations differ on whether the exams and prescriptions are safe for patients; 10 states now have similar bans. Medscape Medical News
Blindness, Vision Problems Expected to Double by 2050 in US
By 2050, the prevalence of visual impairment in the United States is projected to exceed 8 million, according to a new analysis. Medscape Medical News
Corneal Crosslinking: Advancing the Treatment of Keratoconus
Corneal transplantation has been the only curative treatment for progressive keratoconus until now. Drs Rapuano and Feldman discuss a newly approved treatment option that is available. Wills Eye Hospital
Crosslinking-Enhanced Hyperopic LASIK: No Regression Benefit
The addition of corneal crosslinking, recently approved by the FDA, to LASIK surgery does not significantly preserve visual acuity, a prospective study shows. Medscape Medical News
Crosslinking-Enhanced LASIK Does Not Add Benefit at 6 Months
The addition of corneal crosslinking, recently approved by the FDA, to LASIK surgery does not significantly preserve visual acuity, a prospective study shows. Medscape Medical News